Next Article in Journal
In Silico Veritas: The Pitfalls and Challenges of Predicting GPCR-Ligand Interactions
Next Article in Special Issue
Improved Histone Deacetylase Inhibitors as Therapeutics for the Neurodegenerative Disease Friedreich’s Ataxia: A New Synthetic Route
Previous Article in Journal
Molecular Determinants of the Response of Tumor Cells to Boswellic Acids
Previous Article in Special Issue
Clinical Toxicities of Histone Deacetylase Inhibitors
Pharmaceuticals 2011, 4(8), 1183-1195; doi:10.3390/ph4081183

Notes on Article Versions

NoteDate
article html file updated22 January 2013 21:00 CET
article html file updated26 January 2013 04:33 CET
article html file updated28 January 2013 23:30 CET
article html file updated6 February 2013 02:07 CET
article html file updated6 February 2013 22:21 CET
article xml file uploaded17 June 2014 04:45 CEST
article html file updated17 June 2014 04:45 CEST
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert